Project Grant K08AI182476
Award Date
1/9/25
Completion Date
12/31/29
Dollars Obligated
$185K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Pennsylvania, USA
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $986,387 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Children's Hospital of Philadelphia (CHOP) to identify cellular proteins associated with recombinant adeno-associated virus (rAAV) genomes. The project aims to employ a novel proteomics technology called IPOND-MS to identify cellular factors that interact with both wild-type AAV genomes and rAAV vector genomes during replication and...
This federal Project Grant award of $534,000.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate how antigen location and peptide-MHC class II (pMHCII) complex density and half-life can drive CD4+ T cell differentiation and functionality. The research, conducted by the Children's Hospital of Philadelphia (CHOP), aims to test a model proposing that extracellular...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $2,660,212 to The Children's Hospital Corporation (Boston Children's Hospital) to develop armed nanobodies as anti-infectives and anti-tumor agents. The key products and services to be delivered under this grant include: Investigating the mechanisms of action (ADCC and CDC) of a nanobody that recognizes...
This $456,390.00 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant is intended to fund research to understand how antigen duration and vaccine construct modulate the infant immune response to influenza vaccines. Specifically, the research seeks to elucidate the mechanisms by which a prolonged antigen delivery approach can significantly increase protective antibody...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $658,426 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Children's Hospital of Philadelphia (CHOP) on December 20, 2024. The grant will fund research to investigate the role of chronic STAT3 signaling and CD39 upregulation in impairing CD8 T cell function in patients with STAT3 gain-of-function (GOF) disease. Specifically, the research aims to determine how increased CD39 expression in...
This $3,454,926 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research aimed at developing an HIV-1 vaccine strategy focused on the "apex" epitope of the HIV envelope glycoprotein. The research seeks to identify and characterize HIV broadly neutralizing antibody (bNAb) precursors that target the apex epitope, and to design envelope protein antigens that can...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $781,685 in funding to The Children's Hospital of Philadelphia (CHOP) to conduct research on the molecular circuits controlling human T follicular regulatory (Tfr) cell development. The key objectives are to establish the lineage and function of different Tfr cell subsets, examine their localization within...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $489,500.00 to The Children's Hospital of Philadelphia (CHOP) to conduct research on the cellular identity of the intact HIV reservoir. The key objectives are to: 1) Investigate the transcriptional differences between CD4+ T cells with provirus in closed versus open chromatin, and 2) Identify the distinct...
This federal Project Grant award of $350,000 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to develop polymer-derived biomaterials for messenger RNA (mRNA) delivery to induce antigen-specific immune tolerance. The award supports research to evaluate diverse nanocarrier formulations encapsulating antigens and mRNAs encoding tolerogenic proteins, investigate the biodistribution and...
This $404,479 federal project grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will support research to develop mechanistic insights into the kinetics of Fc receptor-mediated placental antibody transfer. The goal is to optimize maternal vaccine strategies to maximize newborn immunization against serious infections. The key products and services to be delivered under this 5-year grant...